NCT01678300View on ClinicalTrials.gov

Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Ulcerative Colitis
Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01678300 - Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) | Biotech Hunter | Biotech Hunter